To access the full text documents, please follow this link: http://hdl.handle.net/2445/110383
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Sanmartí Sala, Raimon |
dc.contributor.author | Inciarte-Mundo, Jose |
dc.contributor.author | Estrada-Alarcon, Paula |
dc.contributor.author | Garcia-Manrique, Maria |
dc.contributor.author | Narváez García, Francisco Javier |
dc.contributor.author | Rodríguez Moreno, Jesús |
dc.contributor.author | Gomez-Centeno, Antoni |
dc.contributor.author | Pascal, Mariona |
dc.contributor.author | Yagüe, Jordi |
dc.date | 2017-05-03T10:54:53Z |
dc.date | 2017-05-03T10:54:53Z |
dc.date | 2015-08 |
dc.date | 2017-05-03T10:54:54Z |
dc.identifier.citation | 0003-4967 |
dc.identifier.citation | 657895 |
dc.identifier.uri | http://hdl.handle.net/2445/110383 |
dc.format | 1 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | BMJ Publishing Group |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2015-207530 |
dc.relation | Annals of the Rheumatic Diseases, 2015, vol. 74, num. 8, p. e42 |
dc.relation | https://doi.org/10.1136/annrheumdis-2015-207530 |
dc.rights | (c) BMJ Publishing Group, 2015 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Artritis reumatoide |
dc.subject | Medicaments |
dc.subject | Administració de medicaments |
dc.subject | Sistema immunològic |
dc.subject | Anticossos monoclonals |
dc.subject | Rheumatoid arthritis |
dc.subject | Drugs |
dc.subject | Administration of drugs |
dc.subject | Immune system |
dc.subject | Monoclonal antibodies |
dc.title | Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract | |
dc.description.abstract |